Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis

Mult Scler. 2011 Jun;17(6):666-71. doi: 10.1177/1352458510394398. Epub 2011 Jan 6.

Abstract

Background: The relative contribution and interaction of risk factors for multiple sclerosis (MS) have not been evaluated.

Objectives: To determine whether vitamin D status is associated with antibody levels to common viruses in pediatric-onset MS or clinically isolated syndrome (CIS) patients and controls.

Methods: We assessed whether vitamin D status was associated with viral antibody levels to Epstein-Barr virus, cytomegalovirus (CMV), and herpes simplex virus (HSV)-1 or -2 in subjects who demonstrated evidence of remote infection with these viruses and whether these associations differed depending on disease status.

Results: In 140 subjects, vitamin D status was weakly associated with antibody levels to CMV but not to the other viruses. However, there were some interactions between vitamin D status and disease state. Among those with vitamin D sufficiency (≥30 ng/ml), MS/CIS patients had higher antibody levels to Epstein-Barr nuclear antigen-1 than controls. Vitamin D sufficiency was associated with higher CMV antibody levels in MS/CIS subjects but lower CMV antibody levels in controls. Higher vitamin D levels appeared to be associated with higher titers to HSV-2 in MS/CIS patients but not controls.

Conclusions: Vitamin D status may be differentially associated with antibody levels to common childhood viruses among seropositive subjects.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age of Onset
  • Antibodies, Viral / blood*
  • Biomarkers / blood
  • Calcifediol / blood
  • Calcifediol / deficiency*
  • Case-Control Studies
  • Child
  • Cross-Sectional Studies
  • Cytomegalovirus / immunology
  • Demyelinating Diseases / blood
  • Demyelinating Diseases / epidemiology
  • Demyelinating Diseases / virology
  • Female
  • Herpesvirus 1, Human / immunology
  • Herpesvirus 2, Human / immunology
  • Herpesvirus 4, Human / immunology
  • Humans
  • Linear Models
  • Male
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / epidemiology
  • Multiple Sclerosis / virology
  • New York / epidemiology
  • Risk Assessment
  • Risk Factors
  • San Francisco / epidemiology
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / epidemiology*

Substances

  • Antibodies, Viral
  • Biomarkers
  • Calcifediol